Literature DB >> 29253764

The role of MCM5 expression in cervical cancer: Correlation with progression and prognosis.

Dan Wang1, Qian Li1, Yichun Li2, Hongyan Wang3.   

Abstract

Minichromosome maintenance protein 5 (MCM5) has been suggested overexpressed in cervical cancer, but the clinical value and biological function of MCM5 in cervical cancer is still unknown. In our study, MCM5 mRNA and protein were significantly overexpressed in cervical cancer tissues and cell lines compared with normal cervical tissues and cell lines, and were obviously increased in cervical adenocarcinoma tissues and cell lines in comparison to cervical squamous cell carcinoma tissues and cell lines. In cervical adenocarcinoma patients, we firstly found that MCM5 expression was closely correlated with clinical stage, lymph node metastasis, distant metastasis and histological grade. Univariate and multivariate analysis showed MCM5 high-expression was an independent unfavorable prognostic factor. In conclusion, MCM5 is associated with the malignant status and poor prognosis in cervical adenocarcinoma patients, and modulates cervical adenocarcinoma cells proliferation.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Biomarker; Cervical adenocarcinoma; Cervical cancer; MCM5; Proliferation

Mesh:

Substances:

Year:  2017        PMID: 29253764     DOI: 10.1016/j.biopha.2017.12.006

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  9 in total

1.  MCM5 promotes tumour proliferation and correlates with the progression and prognosis of renal cell carcinoma.

Authors:  Binbin Gong; Ming Ma; Xiaorong Yang; Wenjie Xie; Yanping Luo; Ting Sun
Journal:  Int Urol Nephrol       Date:  2019-06-12       Impact factor: 2.370

2.  An integrated analysis of single-cell and bulk transcriptomics reveals EFNA1 as a novel prognostic biomarker for cervical cancer.

Authors:  Xiaopeng Shen; Meng Li; Yang Lei; Shan Lu; Sufen Wang; Zhongxian Liu; Chunguang Wang; Yun Zhao; Ao Wang; Chao Bi; Guoping Zhu
Journal:  Hum Cell       Date:  2022-01-24       Impact factor: 4.174

3.  Risk factors for vitamin D deficiency in sickle cell disease.

Authors:  Jin Han; Xu Zhang; Santosh L Saraf; Michel Gowhari; Robert E Molokie; Johara Hassan; Shivi Jain; Binal N Shah; Taimur Abbasi; Roberto F Machado; Victor R Gordeuk
Journal:  Br J Haematol       Date:  2018-05-16       Impact factor: 6.998

4.  PMEPA1 Serves as a Prognostic Biomarker and Correlates with Immune Infiltrates in Cervical Cancer.

Authors:  Jing Li; Wei-Min Kong
Journal:  J Immunol Res       Date:  2022-04-20       Impact factor: 4.493

5.  Distinct Diagnostic and Prognostic Values of Minichromosome Maintenance Gene Expression in Patients with Hepatocellular Carcinoma.

Authors:  Xiwen Liao; Xiaoguang Liu; Chengkun Yang; Xiangkun Wang; Tingdong Yu; Chuangye Han; Ketuan Huang; Guangzhi Zhu; Hao Su; Wei Qin; Rui Huang; Long Yu; Jianlong Deng; Xianmin Zeng; Xinping Ye; Tao Peng
Journal:  J Cancer       Date:  2018-06-12       Impact factor: 4.207

6.  MiR-362-3p functions as a tumor suppressor through targeting MCM5 in cervical adenocarcinoma.

Authors:  Dan Wang; Hongyan Wang; Yichun Li; Qian Li
Journal:  Biosci Rep       Date:  2018-06-21       Impact factor: 3.840

7.  Elevated expression of minichromosome maintenance 3 indicates poor outcomes and promotes G1/S cell cycle progression, proliferation, migration and invasion in colorectal cancer.

Authors:  He Zhou; Yongfu Xiong; Guangjun Zhang; Zuoliang Liu; Lifa Li; Songlin Hou; Tong Zhou
Journal:  Biosci Rep       Date:  2020-07-31       Impact factor: 3.840

8.  Prognostic value of minichromosome maintenance mRNA expression in early-stage pancreatic ductal adenocarcinoma patients after pancreaticoduodenectomy.

Authors:  Xiwen Liao; Chuangye Han; Xiangkun Wang; Ketuan Huang; Tingdong Yu; Chengkun Yang; Rui Huang; Zhengqian Liu; Quanfa Han; Tao Peng
Journal:  Cancer Manag Res       Date:  2018-09-05       Impact factor: 3.989

9.  MCM2-7 in Clear Cell Renal Cell Carcinoma: MCM7 Promotes Tumor Cell Proliferation.

Authors:  Junneng Zhang; Huanzong Zhang; Yinghui Wang; Qingshui Wang
Journal:  Front Oncol       Date:  2021-12-21       Impact factor: 6.244

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.